Coastwise Capital Group LLC boosted its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 11.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,694 shares of the exchange traded fund’s stock after purchasing an additional 465 shares during […]